VirExit Technologies, Inc. Stock

Equities

VXIT

US92767Q1022

Business Support Supplies

Market Closed - OTC Markets 15:29:39 2024-04-26 EDT 5-day change 1st Jan Change
0.0008 USD 0.00% Intraday chart for VirExit Technologies, Inc. 0.00% +33.33%
Sales 2017 0.03 0.04 Sales 2018 - Capitalization 3.23M 4.42M
Net income 2017 -1M -1.37M Net income 2018 -1M -1.37M EV / Sales 2017 655,261,150 x
Net Debt 2017 572K 782K Net Debt 2018 1.28M 1.75M EV / Sales 2018 -
P/E ratio 2017
-10.3 x
P/E ratio 2018
-1.64 x
Employees 2
Yield 2017 *
-
Yield 2018
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
3 months+14.29%
6 months+14.29%
Current year+33.33%
More quotes
1 week
0.00
Extreme 0.0007
0.00
1 month
0.00
Extreme 0.0007
0.00
Current year
0.00
Extreme 0.0003
0.00
1 year
0.00
Extreme 0.0003
0.00
3 years
0.00
Extreme 0.0003
0.06
5 years
0.00
Extreme 0.0001
0.12
10 years
0.00
Extreme 0.0001
5.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 20-04-30
Director of Finance/CFO 75 -
Chief Operating Officer 56 21-04-18
Members of the board TitleAgeSince
Chief Executive Officer 66 20-04-30
Director of Finance/CFO 75 -
More insiders
Date Price Change Volume
24-04-26 0.0008 0.00% 431,876
24-04-25 0.0008 0.00% 92,393
24-04-24 0.0008 +14.29% 3,711,962
24-04-23 0.0007 -14.63% 2,992,505
24-04-22 0.00082 +2.50% 414,033

Delayed Quote OTC Markets, April 26, 2024 at 03:29 pm

More quotes
VirExit Technologies, Inc. (VXIT) provides safe products within the antiviral space. The Company is also focused on creating a primary sales and marketing platform as a vertical online marketplace to provide a single source for buyers and sellers of protective products and services. Its products include disinfectant cleaners, antiviral medications, personal protective equipment (PPE) and sterilization systems. Its brands include VirExit(r) and VirExit.com. Its Lexian product is an Ultraviolet-C-based device which operates by optically diffusing energy over a specified area to disable viruses and bacteria.
More about the company